Leucine aminopeptidase 3 pseudogene 2 (LAP3P2)

Leucine aminopeptidase 3 pseudogene 2 (LAP3P2) is a pseudogene, meaning it is a non-functional genomic DNA sequence similar to the functional leucine aminopeptidase 3 (LAP3) gene but rendered inactive by disabling mutations. Pseudogenes do not encode functional proteins and typically do not have biological, therapeutic, or disease-related roles. They are considered genetic relics or evolutionary remnants, and unlike their protein-coding counterparts, they do not serve as therapeutic targets in drug discovery or clinical practice[1][4][6]. Pseudogenes like LAP3P2 are classified as non-functional DNA elements that result from duplication or retrotransposition events; they lack the capacity to encode a functional protein due to disruptive mutations such as premature stop codons or frameshifts[1][6]. LAP3P2 is explicitly labeled as a pseudogene in major gene databases and lacks documented functional, structural, or targeting characteristics typical of molecules considered drug targets (e.g., receptor, enzyme, transporter)[4]. There is no information in scientific or medical resources supporting LAP3P2 as a biomarker, disease association, or therapeutic target. The functional “parent” gene is LAP3 (Leucine aminopeptidase 3), which is a bona fide enzyme involved in proteolysis and has roles in cell migration, cancer, and metabolism, but LAP3P2 lacks these attributes[3][7]. Pseudogenes are sometimes transcribed or involved in gene regulation, but there is no evidence that LAP3P2 has such functions or roles[1][6].

Other names

LAP3P2Leucine aminopeptidase 3 pseudogene 2